CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells.

Source:http://linkedlifedata.com/resource/pubmed/id/21779359

Download in:

View as

General Info

PMID
21779359